Johnson & Johnson
Johnson & Johnson (JNJ) — Form 10-Q: Quarterly report
AI-generated summary
Johnson & Johnson filed its quarterly report on Form 10-Q for the period ended September 27, 2026. Worldwide sales for the first nine months of 2026 reached $74.8 billion, representing a 7.4% increase compared to the same period in 2025. Earnings before provision for taxes on income for the nine-month period were $12.8 billion, which included a charge of approximately $5.5 billion related to the proposed talc ovarian litigation resolution.
Key facts
- Document
- 10-Q
More JNJ filings
- 13F-HR
Filed Oct 26, 2026
- 8-K
Filed Oct 13, 2026
- 4
Filed Sep 10, 2026
- 4
Filed Sep 10, 2026
- 4
Filed Sep 10, 2026
- 4
Filed Sep 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.